FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489366589> ?p ?o ?g. }

• W1489366589 endingPage "241" @default.
• W1489366589 startingPage "231" @default.
• W1489366589 abstract "This review describes the antibodies formed against mammalian extracellular matrix (ECM) implants in humans and proposes methods for avoiding the detrimental effects of these antibodies. There are two types of antibodies against ECM implants: (i) The natural anti-Gal antibody constituting ∼1% of immunoglobulins in humans. This antibody binds to a carbohydrate antigen called the α-gal epitope with the structure Galα1-3Galβ1-4GlcNAc-R. The α-gal epitope is abundant in nonprimate mammals, including on ECM proteins and proteoglycans. Moreover, anti-Gal antibody titers increase within 2–4 weeks by 10- to 100-folds in human recipients of mammalian implants or xenografts expressing α-gal epitopes. (ii) Anti-non gal antibodies formed against ECM peptide sequences differing from those in homologous proteins in humans. Most homologous proteins in mammals contain immunogenic peptides that elicit anti-non gal antibody production when introduced into humans. Formation of anti-non gal antibodies is much slower than that of elicited anti-Gal antibodies. Both anti-Gal and anti-non gal antibodies are detrimental to ECM implant regeneration in humans by binding to the ECM and directing extensive macrophage-mediated degradation of the implant. In addition, antibodies binding to ECM proteins/proteoglycans may hinder stem cells interaction with the ECM, which is required for directing stem cell differentiation. The anti-Gal immunological barrier can be avoided by using mammalian ECM implants lacking α-gal epitopes. Such implants can be engineered by enzymatic destruction of α-gal epitopes with recombinant α-galactosidase. Alternatively, implants may be obtained from α1,3galactosyltransferase knockout donor species that lack α-gal epitopes. Since postimplantation production of anti-non gal antibodies is a slow process, the detrimental effects of these antibodies may be avoided by accelerating stem cells recruitment into implants, thus accelerating the regeneration process. Acceleration of stem cell recruitment may be achieved by introducing α-gal nanoparticles into the implant. α-Gal nanoparticles present multiple α-gal epitopes, which bind anti-Gal and induce recruitment of macrophages by generating complement chemotactic factors. Fc/Fcγ receptor interaction between anti-Gal coating α-gal nanoparticles and recruited macrophages activates the macrophages to secrete “pro-healing” cytokines/growth factors that recruit stem cells. These recruited cells are instructed by the implanted ECM to regenerate the implant before anti-non gal antibodies can reach detrimental titers." @default.
• W1489366589 created "2016-06-24" @default.
• W1489366589 creator A5071451603 @default.
• W1489366589 date "2015-04-01" @default.
• W1489366589 modified "2023-10-16" @default.
• W1489366589 title "Avoiding Detrimental Human Immune Response Against Mammalian Extracellular Matrix Implants" @default.
• W1489366589 cites W1484684784 @default.
• W1489366589 cites W1501761217 @default.
• W1489366589 cites W1501914218 @default.
• W1489366589 cites W1570041557 @default.
• W1489366589 cites W1578786432 @default.
• W1489366589 cites W1618744733 @default.
• W1489366589 cites W164508869 @default.
• W1489366589 cites W1784039760 @default.
• W1489366589 cites W1893693153 @default.
• W1489366589 cites W1903287340 @default.
• W1489366589 cites W1963828447 @default.
• W1489366589 cites W1963940108 @default.
• W1489366589 cites W1969456018 @default.
• W1489366589 cites W1969713193 @default.
• W1489366589 cites W1972357761 @default.
• W1489366589 cites W1982277347 @default.
• W1489366589 cites W1982358713 @default.
• W1489366589 cites W1990569265 @default.
• W1489366589 cites W1990923023 @default.
• W1489366589 cites W1992426307 @default.
• W1489366589 cites W1995709850 @default.
• W1489366589 cites W1995978414 @default.
• W1489366589 cites W1996031005 @default.
• W1489366589 cites W1999416747 @default.
• W1489366589 cites W2000706152 @default.
• W1489366589 cites W2003924286 @default.
• W1489366589 cites W2005740395 @default.
• W1489366589 cites W2007658022 @default.
• W1489366589 cites W2008565536 @default.
• W1489366589 cites W2009315388 @default.
• W1489366589 cites W2023401944 @default.
• W1489366589 cites W2026778488 @default.
• W1489366589 cites W2027574957 @default.
• W1489366589 cites W2029453795 @default.
• W1489366589 cites W2031569503 @default.
• W1489366589 cites W2035442517 @default.
• W1489366589 cites W2040820272 @default.
• W1489366589 cites W2041622941 @default.
• W1489366589 cites W2043711606 @default.
• W1489366589 cites W2044487888 @default.
• W1489366589 cites W2047999162 @default.
• W1489366589 cites W2050072456 @default.
• W1489366589 cites W2057607651 @default.
• W1489366589 cites W2057752522 @default.
• W1489366589 cites W2059486645 @default.
• W1489366589 cites W2061244510 @default.
• W1489366589 cites W2065216214 @default.
• W1489366589 cites W2069535135 @default.
• W1489366589 cites W2078763854 @default.
• W1489366589 cites W2078854426 @default.
• W1489366589 cites W2083418120 @default.
• W1489366589 cites W2085878243 @default.
• W1489366589 cites W2090303367 @default.
• W1489366589 cites W2092975980 @default.
• W1489366589 cites W2093535158 @default.
• W1489366589 cites W2095470662 @default.
• W1489366589 cites W2098252984 @default.
• W1489366589 cites W2110762398 @default.
• W1489366589 cites W2119970428 @default.
• W1489366589 cites W2121635085 @default.
• W1489366589 cites W2121996637 @default.
• W1489366589 cites W2126716187 @default.
• W1489366589 cites W2126878361 @default.
• W1489366589 cites W2129470836 @default.
• W1489366589 cites W2133785873 @default.
• W1489366589 cites W2135073071 @default.
• W1489366589 cites W2143634863 @default.
• W1489366589 cites W2143654986 @default.
• W1489366589 cites W2146092834 @default.
• W1489366589 cites W2148591507 @default.
• W1489366589 cites W2150538563 @default.
• W1489366589 cites W2157203184 @default.
• W1489366589 cites W2158646376 @default.
• W1489366589 cites W2170780801 @default.
• W1489366589 cites W2171720113 @default.
• W1489366589 cites W2328824353 @default.
• W1489366589 cites W2418363127 @default.
• W1489366589 cites W4211163267 @default.
• W1489366589 cites W4235120461 @default.
• W1489366589 cites W4238594062 @default.
• W1489366589 cites W4362203941 @default.
• W1489366589 cites W72690461 @default.
• W1489366589 doi "https://doi.org/10.1089/ten.teb.2014.0392" @default.
• W1489366589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25315097" @default.
• W1489366589 hasPublicationYear "2015" @default.
• W1489366589 type Work @default.
• W1489366589 sameAs 1489366589 @default.
• W1489366589 citedByCount "44" @default.
• W1489366589 countsByYear W14893665892015 @default.
• W1489366589 countsByYear W14893665892016 @default.
• W1489366589 countsByYear W14893665892017 @default.
• W1489366589 countsByYear W14893665892018 @default.

• next